Related Experiment Videos
Signal transduction via serine/threonine kinase receptors
K Miyazono1, P ten Dijke, H Yamashita
1Ludwig Institute for Cancer Research, Biomedical Center, Uppsala, Sweden.
Abstract:
A number of serine/threonine kinase receptors have recently been identified. Most of the members of this family are type I or type II receptors for proteins in the transforming growth factor-beta (TGF-beta) superfamily. The type I and type II receptors form heteromeric receptor complexes after binding of the ligands, and transduce intracellular signals. TGF-beta type I receptor needs type II receptor for ligand binding, and type II receptor needs type I receptor for signalling. The signal transducing molecules that interact with heteromeric serine/threonine kinase receptor complexes remain to be elucidated; cyclin-dependent kinases and the retinoblastoma protein appear to be downstream elements in the antiproliferative pathway of TGF-beta.
Insights
New serine/threonine kinase receptors, including transforming growth factor-beta (TGF-beta) type I and type II receptors, form complexes to signal cells. Downstream elements like cyclin-dependent kinases are involved in TGF-beta
Area of Science:
- Cellular signaling pathways
- Molecular biology
- Receptor tyrosine kinases
Background:
- Serine/threonine kinase receptors are crucial for cellular communication.
- Many are identified as receptors for the transforming growth factor-beta (TGF-beta) superfamily.
- These receptors function as Type I and Type II units.
Purpose of the Study:
- To investigate the roles of Type I and Type II serine/threonine kinase receptors.
- To understand the formation of heteromeric receptor complexes.
- To identify downstream signaling molecules in TGF-beta pathways.
Main Methods:
- Identification of novel serine/threonine kinase receptors.
- Analysis of heteromeric complex formation between Type I and Type II receptors.
- Investigation of intracellular signal transduction pathways.
Main Results:
- Type I and Type II receptors form heteromeric complexes upon ligand binding.
- Type II receptors are necessary for ligand binding, while Type I receptors are essential for signaling.
- Cyclin-dependent kinases and retinoblastoma protein are identified as downstream elements in the TGF-beta antiproliferative pathway.
Conclusions:
- Heteromeric complexes of Type I and Type II serine/threonine kinase receptors mediate TGF-beta superfamily signaling.
- The precise signal transducing molecules interacting with these complexes require further elucidation.
- Cyclin-dependent kinases and retinoblastoma protein play roles in the antiproliferative effects of TGF-beta.